Page 727 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 727

702                                        CHAPTER 3



  VetBooks.ir  3.161                                      3.162





















                                                          Fig. 3.162  Cytology of BAL fluid from a horse
                                                          with heaves during exacerbation of clinical signs.
                                                          Well-preserved neutrophils (black arrows) are
           Fig. 3.161  Bronchoscopic view of the carina in a horse   the predominant cell type. Pulmonary alveolar
           with heaves during severe exacerbation of clinical signs.   macrophages are also visible (red arrow).
           The carina is markedly blunted due to oedema, and
           flecks of mucus are visible. Airways are hyperresponsive,
           resulting in excessive coughing and constriction of the   fluticasone) routes of administration (Table  3.4).
           airways in response to passage of the bronchoscope.  Oral administration of prednisone should be
                                                          avoided because it is poorly absorbed, and the active
                                                          metabolite is not reliably produced in many horses.
           Management                                     More severely affected animals will require initial
           Clinical cure is not generally possible in horses with   therapy with systemically administered corticoste-
           heaves, so treatment is aimed at achieving and main-  roids before inhaled corticosteroids are considered.
           taining remission from clinical signs. This is best   A  tapering course of corticosteroid administration
           done  through persistent  and  aggressive  environ-  over 2–4 weeks is commonly required.
           mental management to reduce exposure to inhaled   During episodes of heaves exacerbation, rescue
           allergens (Table 3.3). Hay should be good quality   therapy may be required in animals demonstrat-
           with minimal dust and moulds present, or preferably   ing dyspnoea or respiratory distress. This is best
           changed to haylage, or the animal may benefit from   achieved through bronchodilation with rapid- acting
           transition to a pelleted complete feed. Continuous   drugs such as beta-2 adrenergics (e.g. albuterol,
           pasture turnout is recommended to optimise venti-  levalbuterol, salbutamol, clenbuterol), followed by
           lation. If the animal is to be housed indoors for any   longer-acting bronchodilation (e.g. salmeterol).
           period of time, effort should be made to avoid peri-  Chronic use of beta-agonist medications such as
           ods of dusty activities such as during cleaning and   clenbuterol  leads  to  tolerance  or  desensitisation  to
           bedding of stalls, feeding hay and sweeping. The   the drug, and current recommendations are to limit
           stall should also not be located near to an arena or   use to 2 weeks.
           hay-storage facility; overhead hay storage is particu-  One  controlled  study  showed  improvement  of
           larly detrimental. Bedding should be wood shavings   clinical signs of heaves after administration of an
           or peat moss rather than straw or sawdust.     omega-3 polyunsaturated fatty acid supplement con-
             Alleviation of lung inflammation is achieved   taining docosahexaenoic acid (1.5–3 g) and a low-dust
           through therapy with corticosteroids given via oral   diet for 2 months. Some practitioners report using
           (e.g. prednisolone), parenteral (e.g. isoflupredone,   skin allergen testing or serum antibody   testing to
           dexamethasone) or inhalation (e.g. beclomethasone,   direct allergen desensitisation treatment, but there
   722   723   724   725   726   727   728   729   730   731   732